Arkolith/Insider Trading/OPNT/Form 4

Skolnick Phil

Chief Scientific OfficerOPIANT PHARMACEUTICALS, INC. (OPNT) · full profile →Form 4 · filed Jan 31, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2023Sell(S)480$20.26$10K22K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001385508-23-000031) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML